Skip to content

Medical-device intelligence

GQL: Antisera, Fluorescent, Herpesvirus Hominis 1,2

FDA product code GQL: Antisera, Fluorescent, Herpesvirus Hominis 1,2. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
GQL
FDA device name
Antisera, Fluorescent, Herpesvirus Hominis 1,2
Device class
2
Regulation number
866.3305
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

37 clearance records and 0 recall records in the covered releases, across 23 source company names and 1 product codes. Dated history runs from Jul 11, 1977 to Aug 28, 2009.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
GQL · Antisera, Fluorescent, Herpesvirus Hominis 1,2370

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

37 matching records
Device / recordCompany in FDA recordSourceSource date
ELVIS HSV ID AND D3 TYPING TEST SYSTEMK091753 · GQLDiagnostic Hybrids, Inc.510(k)Aug 28, 2009FDA decision date
LIGHT DIAGNOSTICS HSV 1/2 TYPING DFA KITK081527 · GQLMillipore Corporation510(k)Apr 1, 2009FDA decision date
THE APTUS(AUTOMATED) APPLICATION OF THE HSV-2 IGG ELISA TEST SYSTEM. AN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FOR THK984120 · GQLZeus Scientific, Inc.510(k)May 26, 1999FDA decision date
THE APTUS (AUTOMATED) APPLICATION OF THE HSV-1 IGG ELISA TEST SYSTEM. AN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FORK984135 · GQLZeus Scientific, Inc.510(k)May 26, 1999FDA decision date
INDIRECT FLUORESCENT ASSAY FOR HERPES SIMPLEX 1K905608 · GQLStellar Bio Systems, Inc.510(k)Nov 7, 1991FDA decision date
HERPES SIMPLEX VIRUS TISSUE CULTURE CONF. TYPINGK904095 · GQLCalifornia Integrated Diagnostics, Inc.510(k)Feb 1, 1991FDA decision date
PATHODX HERPES TYPINGK904167 · GQLDiagnostic Products Corp.510(k)Dec 13, 1990FDA decision date
BARTELS HERPES SIMPLEX VIR FLU MONO ANTIB HSV-1&2K902661 · GQLBaxter Healthcare Corp510(k)Jul 31, 1990FDA decision date
BARTELS HERPES SIMPLEX VIR FLU MONO ANTIBODY TESTK902662 · GQLBaxter Healthcare Corp510(k)Jul 31, 1990FDA decision date
HSV-1 ELISA TEST SYSTEMK891162 · GQLZeus Scientific, Inc.510(k)Jun 20, 1989FDA decision date
HSV-2 ELISA TEST SYSTEMK891782 · GQLZeus Scientific, Inc.510(k)Jun 20, 1989FDA decision date
ORTHO HSV 1&2 DICHROMATIC TYPING REAGENT & SLIDESK891382 · GQLOrtho Diagnostic Systems, Inc.510(k)Jun 6, 1989FDA decision date
HERPES SIMPLEX ANTIBODY TEST FOR DECT. OF HSV 1&2K870814 · GQLMicroscan Div. Baxter Healthcare Corp.510(k)Jun 4, 1987FDA decision date
DIAGNON HERPES IMMUNOPEROXIDASE TYPING TESTK851635 · GQLDiagnon Corp.510(k)Oct 10, 1985FDA decision date
ORTHO DNA PROBE HSV CONFIRMATION TESTK852360 · GQLOrtho Diagnostic Systems, Inc.510(k)Sep 12, 1985FDA decision date
PATHFINDER DETECTION & COLLECTION KITS-HERPES SIMPK852125 · GQLKallestad Laboratories, Inc.510(k)Jul 30, 1985FDA decision date
CELLMATICS HERPES SIMPLEX VIRUS DETECT-SYSK851372 · GQLDifco Laboratories, Inc.510(k)Jul 12, 1985FDA decision date
GIBCO HERPES ID KITK841943 · GQLGibco Laboratories Life Technologies, Inc.510(k)Mar 13, 1985FDA decision date
AMENDMENT TO LABELING MICROTRAK HSV 1/HSV 2 DIRECTK850739 · GQLSyva Co.510(k)Mar 11, 1985FDA decision date
CULTURESET HSV ISOLATION & ID SYSK842216 · GQLOrtho Diagnostic Systems, Inc.510(k)Jan 29, 1985FDA decision date
MICROTRAK HSV 1 & 2 DIRECT SPECIMANK841190 · GQLSyva Co.510(k)Jan 18, 1985FDA decision date
SCOTT SELECTICULT-HSV ISOLATION &K841680 · GQLScott Laboratories, Inc.510(k)Oct 30, 1984FDA decision date
MICROTRAK HSV 1 & 2 CULTUREK840494 · GQLSyva Co.510(k)May 7, 1984FDA decision date
HERPES IDENT. & TYPING TEST HITTK831504 · GQLElectro-Nucleonics Laboratories, Inc.510(k)Sep 20, 1983FDA decision date
HSV IGM TESTK830865 · GQLGull Laboratories, Inc.510(k)Jul 18, 1983FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗